Item 1.01 | Entry into a Material Definitive Agreement. |
On March 8, 2021, Khosla Ventures Acquisition Co. (the “Company”) consummated its initial public offering (the “IPO”) of 34,500,000 shares of Class A common stock, par value $0.0001 per share (the “Public Shares”) of the Company, including the issuance of 4,500,000 Public Shares as a result of the Underwriters’ exercise of their Over-Allotment Option (as defined below) in full. The Public Shares were sold at a price of $10.00 per Public Share, generating gross proceeds to the Company of $345,000,000 (before underwriting discounts and commissions and offering expenses). Pursuant to the Underwriting Agreement (defined below), the Company granted the underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 4,500,000 additional Public Shares solely to cover over-allotments, if any (the “Over-Allotment Option”); and on March 5, 2021, the Underwriters notified the Company that they were exercising the Over-Allotment Option in full.
In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s registration statement on Form S-1 (File No. 333-253096) (the “Registration Statement”):
| • | | An Underwriting Agreement, dated March 3, 2021, among the Company and Goldman Sachs & Co. LLC, as representative of the several underwriters, attached hereto as Exhibit 1.1. |
| • | | An Investment Management Trust Agreement, dated March 3, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee, attached hereto as Exhibit 10.1. |
| • | | A Private Placement Shares Agreement, dated March 3, 2021, between the Company and Khosla Ventures SPAC Sponsor LLC (the “Sponsor”), attached hereto as Exhibit 10.2. |
| • | | A Registration Rights Agreement, dated March 3, 2021, among the Company and certain security holders named therein, attached hereto as Exhibit 10.3. |
| • | | A Forward Purchase Agreement, dated March 3, 2021, among the Company and the Sponsor, attached hereto as Exhibit 10.4. |
| • | | A Letter Agreement, dated March 3, 2021, between the Company, its officers, directors and another securityholder, and the Sponsor, attached hereto as Exhibit 10.5. |
| • | | Indemnity Agreements, each dated March 3, 2021, between the Company and each of its officers and directors, substantially in the form attached hereto as Exhibit 10.6. |
Item 3.02. | Unregistered Sales of Equity Securities. |
Simultaneously with the closing of the IPO, the Company completed the private sale of 990,000 shares of Class A common stock, par value $0.0001 per share (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Share (the “Private Placement”), to the Sponsor, generating gross proceeds to the Company of $9,900,000. The Private Placement Shares are identical to the Public Shares, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Shares (except to certain permitted transferees) until 30 days after the completion of the Company’s initial business combination. The issuance of the Private Placement Shares was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.03. | Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year. |
On March 4, 2021, the Company filed its Second Amended and Restated Certificate of Incorporation in the State of Delaware. The terms of the Second Amended and Restated Certificate of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Second Amended and Restated Certificate of Incorporation is attached as Exhibit 3.1 hereto and is incorporated by reference herein.
A total of $345,000,000, comprised of $338,100,000 of the proceeds from the IPO, including $12,075,000 of the underwriters’ deferred discount, and $6,900,000 of the proceeds from the Private Placement, were placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except
2